Researcher
Gilbert Verbeken
- Keywords:Medicine
- Disciplines:Humanities and the arts, Engineering and technology, Natural sciences
Affiliations
- Surgical clinical sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2015 - Skin Immunology & Immune Tolerance Research Group (Research group)
Member
From1 Oct 2006 → 30 Sep 2015 - Specialities (Department)
Member
From1 Jul 2006 → 31 Dec 2013
Publications
1 - 10 of 14
- Stability of bacteriophages in burn wound care products(2017)
Authors: Maia Merabishvili, Riet Monserez, Jonas van Belleghem, Thomas Rose, Serge Jennes, Daniel De Vos, Gilbert Verbeken, Mario Vaneechoutte, Jean-Paul Pirnay
Pages: e0182121 - Access to bacteriophage therapy(2016)
Authors: Gilbert Verbeken, Isabelle Huys, Daniel De Vos, Arlette De Coninck, Diane Roseeuw, E. Kets, Alain Vanderkelen, Jean Pierre Draye, Thomas Rose, S. Jennes, et al.
- Quality and safety requirements for sustainable phage therapy products(2015)
Authors: Jean-Paul Pirnay, Bob G Blasdel, Laurent Bretaudeau, Angus Buckling, Nina Chanishvili, Jason R Clark, Sofia Corte-Real, Laurent Debarbieux, Alain Dublanchet, Daniel De Vos, et al.
Pages: 2173-2179 - Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium.(2015)
Authors: Jean-Paul Pirnay, E. Baudoux, Olivier Cornu, Alain Delforge, Christian Delloye, Johan Guns, Ernst Heinen, Etienne Van den Abbeel, Alain Vanderkelen, Caroline Van Geyt, et al.
Pages: 557-562 - Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium(2015)
Authors: Jean-Paul Pirnay, Etienne Baudoux, Olivier Cornu, Alain Delforge, Christian Delloye, Johan Guns, Ernst Heinen, Etienne Van Den Abbeel, Alain Vanderkelen, Caroline Van Geyt, et al.
Pages: 557-562 - Cleanrooms and tissue banking how happy I could be with either GMP or GTP?(2013)
Authors: J. Klykens, Jean-Paul Pirnay, O. Giet, E. Baudoux, R. Jashari, Alain Vanderkelen, Nadine Ectors, Gilbert Verbeken, Univ Hosp, Uz Gasthuisberg, et al.
Pages: 571-578 - Paving a regulatory pathway for phage therapy - Europe should muster the resources to financially, technically and legally support the introduction of phage therapy(2013)
Authors: Jean-Paul Pirnay, Lavigne Rob, S. Jennes, D. De Vos, Minne Casteels, Gilbert Verbeken
Pages: 951-954 - Key issues in phage therapy: a report of a dedicated workshop at the viruses of microbes II meeting(2013)
Authors: M Van Eeckhoutte, Gilbert Verbeken, Laurent Debarbieux
Pages: 806-810 - Stability of Staphylococcus aureus Phage ISP after Freeze-Drying (Lyophilization)(2013)
Authors: Maia Meribishvili, C. Vervaet, Jean-Paul Pirnay, D. Devos, Gilbert Verbeken, Jan Mast, Nino Chanisvili, Mario Vaneeckoutte
- Biosimilars and market access: a question of comparability and costs?(2012)
Authors: S. Simoens, Gilbert Verbeken, Katholieke Univ Leuven, Fac Pharmaceut Sci, Res Ctr Pharmaceut Care, [No Value] Pharmacoecon
Pages: 227-231